Cargando…
Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502566/ https://www.ncbi.nlm.nih.gov/pubmed/37616288 http://dx.doi.org/10.1093/stcltm/szad044 |
_version_ | 1785106351002746880 |
---|---|
author | Pieczonka, Katarzyna Nakashima, Hiroaki Nagoshi, Narihito Yokota, Kazuya Hong, James Badner, Anna Chio, Jonathon C T Shibata, Shinsuke Khazaei, Mohamad Fehlings, Michael G |
author_facet | Pieczonka, Katarzyna Nakashima, Hiroaki Nagoshi, Narihito Yokota, Kazuya Hong, James Badner, Anna Chio, Jonathon C T Shibata, Shinsuke Khazaei, Mohamad Fehlings, Michael G |
author_sort | Pieczonka, Katarzyna |
collection | PubMed |
description | Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the lost cells, fiber tracts, and circuits. Neural stem/progenitor cell (NPC) transplantation is a promising strategy that aims to encourage regeneration. However, NPC differentiation remains inconsistent, thus, contributing to suboptimal functional recovery. As such, we have previously engineered oligodendrogenically biased NPCs (oNPCs) and demonstrated their efficacy in a thoracic model of SCI. Since the majority of patients with SCI experience cervical injuries, our objective in the current study was to generate human induced pluripotent stem cell-derived oNPCs (hiPSC-oNPCs) and to characterize these cells in vitro and in vivo, utilizing a clinically relevant rodent model of cervical SCI. Following transplantation, the oNPCs engrafted, migrated to the rostral and caudal regions of the lesion, and demonstrated preferential differentiation toward oligodendrocytes. Histopathological evaluations revealed that oNPC transplantation facilitated tissue preservation while diminishing astrogliosis. Moreover, oNPC transplantation fostered remyelination of the spared tissue. Functional analyses indicated improved forelimb grip strength, gait, and locomotor function in the oNPC-transplanted rats. Importantly, oNPC transplantation did not exacerbate neuropathic pain or induce tumor formation. In conclusion, these findings underscore the therapeutic potential of oNPCs in promoting functional recovery and histopathological improvements in cervical SCI. This evidence warrants further investigation to optimize and advance this promising cell-based therapeutic approach. |
format | Online Article Text |
id | pubmed-10502566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105025662023-09-16 Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model Pieczonka, Katarzyna Nakashima, Hiroaki Nagoshi, Narihito Yokota, Kazuya Hong, James Badner, Anna Chio, Jonathon C T Shibata, Shinsuke Khazaei, Mohamad Fehlings, Michael G Stem Cells Transl Med Pluripotent Stem Cells Traumatic spinal cord injury (SCI) results in the loss of neurons, oligodendrocytes, and astrocytes. Present interventions for SCI include decompressive surgery, anti-inflammatory therapies, and rehabilitation programs. Nonetheless, these approaches do not offer regenerative solutions to replace the lost cells, fiber tracts, and circuits. Neural stem/progenitor cell (NPC) transplantation is a promising strategy that aims to encourage regeneration. However, NPC differentiation remains inconsistent, thus, contributing to suboptimal functional recovery. As such, we have previously engineered oligodendrogenically biased NPCs (oNPCs) and demonstrated their efficacy in a thoracic model of SCI. Since the majority of patients with SCI experience cervical injuries, our objective in the current study was to generate human induced pluripotent stem cell-derived oNPCs (hiPSC-oNPCs) and to characterize these cells in vitro and in vivo, utilizing a clinically relevant rodent model of cervical SCI. Following transplantation, the oNPCs engrafted, migrated to the rostral and caudal regions of the lesion, and demonstrated preferential differentiation toward oligodendrocytes. Histopathological evaluations revealed that oNPC transplantation facilitated tissue preservation while diminishing astrogliosis. Moreover, oNPC transplantation fostered remyelination of the spared tissue. Functional analyses indicated improved forelimb grip strength, gait, and locomotor function in the oNPC-transplanted rats. Importantly, oNPC transplantation did not exacerbate neuropathic pain or induce tumor formation. In conclusion, these findings underscore the therapeutic potential of oNPCs in promoting functional recovery and histopathological improvements in cervical SCI. This evidence warrants further investigation to optimize and advance this promising cell-based therapeutic approach. Oxford University Press 2023-08-24 /pmc/articles/PMC10502566/ /pubmed/37616288 http://dx.doi.org/10.1093/stcltm/szad044 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pluripotent Stem Cells Pieczonka, Katarzyna Nakashima, Hiroaki Nagoshi, Narihito Yokota, Kazuya Hong, James Badner, Anna Chio, Jonathon C T Shibata, Shinsuke Khazaei, Mohamad Fehlings, Michael G Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title | Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title_full | Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title_fullStr | Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title_full_unstemmed | Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title_short | Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model |
title_sort | human spinal oligodendrogenic neural progenitor cells enhance pathophysiological outcomes and functional recovery in a clinically relevant cervical spinal cord injury rat model |
topic | Pluripotent Stem Cells |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502566/ https://www.ncbi.nlm.nih.gov/pubmed/37616288 http://dx.doi.org/10.1093/stcltm/szad044 |
work_keys_str_mv | AT pieczonkakatarzyna humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT nakashimahiroaki humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT nagoshinarihito humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT yokotakazuya humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT hongjames humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT badneranna humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT chiojonathonct humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT shibatashinsuke humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT khazaeimohamad humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel AT fehlingsmichaelg humanspinaloligodendrogenicneuralprogenitorcellsenhancepathophysiologicaloutcomesandfunctionalrecoveryinaclinicallyrelevantcervicalspinalcordinjuryratmodel |